129 related articles for article (PubMed ID: 29653214)
1. Poly(propyleneimine) glycodendrimers non-covalently bind ATP in a pH- and salt-dependent manner - model studies for adenosine analogue drug delivery.
Gorzkiewicz M; Buczkowski A; Appelhans D; Voit B; Pułaski Ł; Pałecz B; Klajnert-Maculewicz B
Int J Pharm; 2018 Jun; 544(1):83-90. PubMed ID: 29653214
[TBL] [Abstract][Full Text] [Related]
2. Maltose modified poly(propylene imine) dendrimers as potential carriers of nucleoside analog 5'-triphosphates.
Szulc A; Signorelli M; Schiraldi A; Appelhans D; Voit B; Bryszewska M; Klajnert-Maculewicz B; Fessas D
Int J Pharm; 2015 Nov; 495(2):940-7. PubMed ID: 26456295
[TBL] [Abstract][Full Text] [Related]
3. Effect of the Structure of Therapeutic Adenosine Analogues on Stability and Surface Electrostatic Potential of their Complexes with Poly(propyleneimine) Dendrimers.
Gorzkiewicz M; Appelhans D; Boye S; Lederer A; Voit B; Klajnert-Maculewicz B
Macromol Rapid Commun; 2019 Aug; 40(15):e1900181. PubMed ID: 31136015
[TBL] [Abstract][Full Text] [Related]
4. Fludarabine-Specific Molecular Interactions with Maltose-Modified Poly(propyleneimine) Dendrimer Enable Effective Cell Entry of the Active Drug Form: Comparison with Clofarabine.
Gorzkiewicz M; Deriu MA; Studzian M; Janaszewska A; Grasso G; Pułaski Ł; Appelhans D; Danani A; Klajnert-Maculewicz B
Biomacromolecules; 2019 Mar; 20(3):1429-1442. PubMed ID: 30707833
[TBL] [Abstract][Full Text] [Related]
5. Sugar-modified poly(propylene imine) dendrimers as drug delivery agents for cytarabine to overcome drug resistance.
Szulc A; Pulaski L; Appelhans D; Voit B; Klajnert-Maculewicz B
Int J Pharm; 2016 Nov; 513(1-2):572-583. PubMed ID: 27667754
[TBL] [Abstract][Full Text] [Related]
6. Studying complexes between PPI dendrimers and Mant-ATP.
Szulc A; Appelhans D; Voit B; Bryszewska M; Klajnert B
J Fluoresc; 2013 Mar; 23(2):349-56. PubMed ID: 23306952
[TBL] [Abstract][Full Text] [Related]
7. Interaction study between maltose-modified PPI dendrimers and lipidic model membranes.
Wrobel D; Appelhans D; Signorelli M; Wiesner B; Fessas D; Scheler U; Voit B; Maly J
Biochim Biophys Acta; 2015 Jul; 1848(7):1490-501. PubMed ID: 25843678
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of Internalization of Maltose-Modified Poly(propyleneimine) Glycodendrimers into Leukemic Cell Lines.
Studzian M; Szulc A; Janaszewska A; Appelhans D; Pułaski Ł; Klajnert-Maculewicz B
Biomacromolecules; 2017 May; 18(5):1509-1520. PubMed ID: 28414464
[TBL] [Abstract][Full Text] [Related]
9. Dense shell glycodendrimers as potential nontoxic anti-amyloidogenic agents in Alzheimer's disease. Amyloid-dendrimer aggregates morphology and cell toxicity.
Klementieva O; Benseny-Cases N; Gella A; Appelhans D; Voit B; Cladera J
Biomacromolecules; 2011 Nov; 12(11):3903-9. PubMed ID: 21936579
[TBL] [Abstract][Full Text] [Related]
10. Glycodendrimer Nanocarriers for Direct Delivery of Fludarabine Triphosphate to Leukemic Cells: Improved Pharmacokinetics and Pharmacodynamics of Fludarabine.
Gorzkiewicz M; Jatczak-Pawlik I; Studzian M; Pułaski Ł; Appelhans D; Voit B; Klajnert-Maculewicz B
Biomacromolecules; 2018 Feb; 19(2):531-543. PubMed ID: 29323872
[TBL] [Abstract][Full Text] [Related]
11. Generation dependent cancer targeting potential of poly(propyleneimine) dendrimer.
Kesharwani P; Tekade RK; Jain NK
Biomaterials; 2014 Jul; 35(21):5539-48. PubMed ID: 24731713
[TBL] [Abstract][Full Text] [Related]
12. Terminal Sugar Moiety Determines Immunomodulatory Properties of Poly(propyleneimine) Glycodendrimers.
Gorzkiewicz M; Sztandera K; Jatczak-Pawlik I; Zinke R; Appelhans D; Klajnert-Maculewicz B; Pulaski Ł
Biomacromolecules; 2018 May; 19(5):1562-1572. PubMed ID: 29569917
[TBL] [Abstract][Full Text] [Related]
13. The influence of maltose modified poly(propylene imine) dendrimers on hen egg white lysozyme structure and thermal stability.
Ciolkowski M; Pałecz B; Appelhans D; Voit B; Klajnert B; Bryszewska M
Colloids Surf B Biointerfaces; 2012 Jun; 95():103-8. PubMed ID: 22410344
[TBL] [Abstract][Full Text] [Related]
14. Poly(propylene imine) dendrimers modified with maltose or maltotriose protect phosphorothioate oligodeoxynucleotides against nuclease activity.
Drzewińska J; Appelhans D; Voit B; Bryszewska M; Klajnert B
Biochem Biophys Res Commun; 2012 Oct; 427(1):197-201. PubMed ID: 22995301
[TBL] [Abstract][Full Text] [Related]
15. Toxicity and proapoptotic activity of poly(propylene imine) glycodendrimers in vitro: considering their contrary potential as biocompatible entity and drug molecule in cancer.
Ziemba B; Franiak-Pietryga I; Pion M; Appelhans D; Muñoz-Fernández MÁ; Voit B; Bryszewska M; Klajnert-Maculewicz B
Int J Pharm; 2014 Jan; 461(1-2):391-402. PubMed ID: 24361266
[TBL] [Abstract][Full Text] [Related]
16. Effect of poly(propylene imine) glycodendrimers on β-amyloid aggregation in vitro and in APP/PS1 transgenic mice, as a model of brain amyloid deposition and Alzheimer's disease.
Klementieva O; Aso E; Filippini D; Benseny-Cases N; Carmona M; Juvés S; Appelhans D; Cladera J; Ferrer I
Biomacromolecules; 2013 Oct; 14(10):3570-80. PubMed ID: 24004423
[TBL] [Abstract][Full Text] [Related]
17. The influence of densely organized maltose shells on the biological properties of poly(propylene imine) dendrimers: new effects dependent on hydrogen bonding.
Klajnert B; Appelhans D; Komber H; Morgner N; Schwarz S; Richter S; Brutschy B; Ionov M; Tonkikh AK; Bryszewska M; Voit B
Chemistry; 2008; 14(23):7030-41. PubMed ID: 18576443
[TBL] [Abstract][Full Text] [Related]
18. Sugar-Modified Poly(propylene imine) Dendrimers Stimulate the NF-κB Pathway in a Myeloid Cell Line.
Jatczak-Pawlik I; Gorzkiewicz M; Studzian M; Appelhans D; Voit B; Pulaski L; Klajnert-Maculewicz B
Pharm Res; 2017 Jan; 34(1):136-147. PubMed ID: 27766462
[TBL] [Abstract][Full Text] [Related]
19. Gd-Chelated poly(propylene imine) dendrimers with densely organized maltose shells for enhanced MR imaging applications.
Xiong Z; Wang Y; Zhu J; He Y; Qu J; Effenberg C; Xia J; Appelhans D; Shi X
Biomater Sci; 2016 Oct; 4(11):1622-1629. PubMed ID: 27722500
[TBL] [Abstract][Full Text] [Related]
20. Interactions of Nitroxide-Conjugated and Non-Conjugated Glycodendrimers with Normal and Cancer Cells and Biocompatibility Studies.
Andreozzi E; Antonelli A; Cangiotti M; Canonico B; Sfara C; Pianetti A; Bruscolini F; Sahre K; Appelhans D; Papa S; Ottaviani MF
Bioconjug Chem; 2017 Feb; 28(2):524-538. PubMed ID: 28068077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
